Predictive model accelerates the development of nanoparticles as potential drug carriers for targeting neurodegenerative ...

October 21, 2025 - Nanoform Finland Plc (“Nanoform”), a leading nanoparticle medicine performance-enhancing company, today announced that key findings from two proof-of-concept studies conducted in ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

Emerging drug delivery systems improve solubility, targeting, and sustained release, offering promise for enhanced gout and ...

This NDA submission is a pivotal step toward U.S. market entry, supporting TAHO Pharma's broader vision to improve patient experiences and therapeutic outcomes through novel drug delivery platforms.

The global Controlled-Release Drug Delivery Technology Market is poised for remarkable growth, estimated at USD 66.9 billion ...

Please provide your email address to receive an email when new articles are posted on . Most patients with non-muscle-invasive bladder cancer who received TAR-200 with gemcitabine achieved complete ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...